Lung Deposition and Inspiratory Flow Rate in Patients with Chronic Obstructive Pulmonary Disease Using Different Inhalation Devices: A Systematic Literature Review and Expert Opinion

Background: Our aim was to describe: 1) lung deposition and inspiratory flow rate; 2) main characteristics of inhaler devices in chronic obstructive pulmonary disease (COPD). Methods: A systematic literature review (SLR) was conducted to analyze the features and results of inhaler devices in COPD pa...

Descripción completa

Detalles Bibliográficos
Autores: Baloira, Adolfo, Abad, Araceli, Fuster Gomila, Antonia, Garcia Rivero, Juan Luis, Garcia-Sidro, Patricia, Marquez-Martin, Eduardo, Palop, Marta, Soler, Nestor, Velasco, JL, Gonzalez-Torralba, Fernando
Tipo de recurso: artículo
Fecha de publicación:2021
País:España
Institución:Instituto de Salud Carlos III (ISCIII)
Repositorio:Repisalud
Idioma:inglés
OAI Identifier:oai:repisalud.isciii.es:20.500.12105/23165
Acceso en línea:https://hdl.handle.net/20.500.12105/23165
Access Level:acceso abierto
Palabra clave:COPD
Lung deposition
Inspiratory flow
Inhalation devices
Systematic literature review
Testimonio de Experto
Enfermedad Pulmonar Obstructiva Crónica
Broncodilatadores
Humanos
Diseño de Equipo
Pulmón
Inhaladores de Dosis Medida
Administración por Inhalación
Inhaladores de Polvo Seco
Lung
Dry Powder Inhalers
Equipment Design
Administration, Inhalation
Pulmonary Disease, Chronic Obstructive
Expert Testimony
Humans
Bronchodilator Agents
Metered Dose Inhalers
Descripción
Sumario:Background: Our aim was to describe: 1) lung deposition and inspiratory flow rate; 2) main characteristics of inhaler devices in chronic obstructive pulmonary disease (COPD). Methods: A systematic literature review (SLR) was conducted to analyze the features and results of inhaler devices in COPD patients. These devices included pressurized metered-dose inhalers (pMDIs), dry powder inhalers (DPIs), and a soft mist inhaler (SMI). Inclusion and exclusion criteria were established, as well as search strategies (Medline, Embase, and the Cochrane Library up to April 2019). In vitro and in vivo studies were included. Two reviewers selected research articles, collected and analyzed data independently. Narrative searches complemented the SLR. We discussed the results of the reviews in a nominal group meeting and agreed on various general principles and recommendations. Results: The SLR included 71 research articles, some were of low-moderate quality, and there was great variability regarding populations and outcomes. Lung deposition rates varied across devices: 8%-53% for pMDIs, 7%-69% for DPIs, and 39%-67% for the SMI. The aerosol exit velocity was high with pMDIs (more than 3 m/s), while it is much slower (0.84-0.72 m/s) with the SMI. In general, pMDIs produce large-sized presearch articles (1.22-8 mu m), DPIs produce medium-sized presearch articles (1.8-4.8 mu m), and 60% of the presearch articles reach an aerodynamic diameter <5 mu m with the SMI. All inhalation devices reach central and peripheral lung regions, but the SMI distribution pattern might be better compared with pMDIs. DPIs' intrinsic resistance is higher than that of pMDIs and SMI, which are relatively similar and low. Depending on the DPI, the minimum flow inspiratory rate required was 30 L/min. pMDIs and SMI did not require a high inspiratory flow rate. Conclusion: Lung deposition and inspiratory flow rate are key factors when selecting an inhalation device in COPD patients.